Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion The Wall Street Journal Novo Nordisk to buy Akero for up to $5.2 billion in new CEO’s revival push CNBC Novo CEO Says Risk-Taking, Deals Are Needed to Win Obesity Race Bloomberg.com Novo Nordisk Is Buying Akero Therapeutics. It’s More Good News for Biotech Stocks. Barron’s Novo buying Akero and its MASH hopeful …
Read More »